论文信息 - ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL - 字舞流文

ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL

P. Sax | D. Haas | E. Acosta | B. Taiwo | A. Stefanescu | Kimberly Smith | R. Gulick | C. Godfrey | C. Wallis | Lu Zheng | B. Sha | Cornelius N. Van Dam | Amesika N. Nyaku | Baiba Bezins | C. V. Van Dam